SG Americas Securities’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
SG Americas Securities's OGN Position: Q2 2026 in Review
SG Americas Securities reduced its Organon & Co (OGN) stake by 57% in Q2 2026, selling an estimated $1.47M and leaving 93,344 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1740.
SG Americas Securities first reported a position in OGN in Q2 2021 and has held it in 18 quarters since. The position peaked at $3.05M in Q2 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- SG Americas Securities held 93,344 shares of Organon & Co worth $1.26M as of Q2 2026.
- SG Americas Securities sold 122,975 Organon & Co shares in Q2 2026, an estimated $1.47M.
- Organon & Co made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1740 holding.
- SG Americas Securities first reported a position in Organon & Co in Q2 2021 and has held it in 18 quarters since.
- SG Americas Securities's Organon & Co position peaked at $3.05M in Q2 2021.
- 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.